Valuation: RTW Biotech Opportunities Ltd

Market Cap 776M 679M 627M 586M 1.1B 73.37B 1.13B 7.55B 2.91B 36.2B 2.91B 2.85B 126B P/E 2024
13.7x
P/E 2025 2.88x
Enterprise Value 770M 674M 622M 581M 1.09B 72.8B 1.12B 7.49B 2.89B 35.92B 2.89B 2.83B 125B EV / Sales 2024
56.5x
EV / Sales 2025 20.2x
Free-Float
79%
Yield 2024 *
-
Yield 2025 -
1 day+0.21%
1 week+6.25%
Current month+8.18%
1 month+8.68%
3 months+25.93%
6 months+8.68%
Current year+10.19%
1 week 2.19
Extreme 2.19
2.41
1 month 2.11
Extreme 2.11
2.41
Current year 1.87
Extreme 1.87
2.41
1 year 1.18
Extreme 1.18
2.41
3 years 1.05
Extreme 1.05
2.41
5 years 0.93
Extreme 0.932
2.41
10 years 0.93
Extreme 0.932
2.5
Director TitleAgeSince
Chairman 70 -
Director/Board Member - 2019-10-29
Director/Board Member 51 2019-09-30
Date Insider Type Main position Quantity % Market Cap.
Jan. 21Buy 16,493 0.0050%
Jan. 21Buy 6,880 0.0021%
25-06-02
Simpson Ltd. (United Kingdom)
BuyCompany 15,000 0.0045%
Change 5-day change 1-year change 3-year change Capi.($)
-0.83%+6.25%+96.69%+91.16% 776M
-1.27%-4.18%+21.03%+104.25% 14.41B
-1.07%-10.14%+52.43%+139.90% 11.87B
+0.77%+1.02%-3.08%+32.28% 8.76B
+0.48%+2.52%-11.76%-11.11% 7.69B
-1.29%-6.80%+33.77%+122.85% 7.38B
-0.08%-1.36%+2.03%+55.94% 6.33B
-0.36%+1.39%+9.38%+19.69% 4.59B
0.00%+1.49%+11.11%+5.83% 4.11B
+0.81%-3.42% - - 3.72B
Average -0.18%-1.40%+23.51%+62.31% 6.96B
Weighted average by Cap. -0.41%-3.27%+18.72%+72.92%

Financials

2024 2025
Net sales 8.19M 7.17M 6.62M 6.18M 11.64M 774M 11.9M 79.66M 30.75M 382M 30.76M 30.08M 1.33B 34.57M 30.27M 27.95M 26.1M 49.13M 3.27B 50.25M 336M 130M 1.61B 130M 127M 5.6B
Net income 34.18M 29.93M 27.63M 25.8M 48.57M 3.23B 49.67M 332M 128M 1.59B 128M 126M 5.53B 245M 215M 198M 185M 348M 23.18B 356M 2.39B 921M 11.44B 921M 901M 39.71B
Net Debt -5.36M -4.69M -4.33M -4.05M -7.62M -507M -7.79M -52.14M -20.13M -250M -20.13M -19.69M -868M -5.99M -5.24M -4.84M -4.52M -8.51M -566M -8.7M -58.23M -22.48M -279M -22.48M -21.99M -969M
Logo RTW Biotech Opportunities Ltd
RTW Biotech Opportunities Ltd is a Guernsey-based company focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. The Company invests in companies developing therapies and technologies that can significantly improve patients' lives. The Company seeks to achieve its investment objective by leveraging the Investment Manager's data-driven pipeline of assets to invest in life sciences companies across various therapeutic categories and product types (including genetic medicines, biologics, traditional modalities, such as small molecule pharmaceuticals and antibodies, and medical devices). It intends to create a diversified portfolio of investments across a range of businesses, each pursuing the development of superior pharmacological or medical therapeutic assets to enhance the quality of life and/or extend patient life. The Company's portfolio is managed by RTW Investments, LP.
Employees
-
Date Price Change Volume
26-06-30 $2.380 -0.83% 3,972
26-06-29 $2.400 +3.00% 626,529
26-06-26 $2.330 -0.43% 1,108,031
26-06-25 $2.340 +1.74% 363,019
26-06-24 $2.300 +2.68% 3,797,551
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.400
Average target price
-